Asparagine endopeptidase is an innovative therapeutic target for neurodegenerative diseases
Introduction: Asparagine endopeptidase (AEP) is a pH-dependent endolysosomal cysteine
protease that cleaves its substrates after asparagine residues. Our most recent study
identifies that it possesses the delta-secretase activity, and that it is implicated in numerous
neurological diseases such as Alzheimer's disease (AD) and stroke. Accumulating evidence
supports that the inhibition of AEP exhibits beneficial effects for treating these devastating
diseases. Areas covered: Based on recent evidence, it is clear that AEP cleaves its …
protease that cleaves its substrates after asparagine residues. Our most recent study
identifies that it possesses the delta-secretase activity, and that it is implicated in numerous
neurological diseases such as Alzheimer's disease (AD) and stroke. Accumulating evidence
supports that the inhibition of AEP exhibits beneficial effects for treating these devastating
diseases. Areas covered: Based on recent evidence, it is clear that AEP cleaves its …
Abstract
Introduction: Asparagine endopeptidase (AEP) is a pH-dependent endolysosomal cysteine protease that cleaves its substrates after asparagine residues. Our most recent study identifies that it possesses the delta-secretase activity, and that it is implicated in numerous neurological diseases such as Alzheimer’s disease (AD) and stroke. Accumulating evidence supports that the inhibition of AEP exhibits beneficial effects for treating these devastating diseases.
Areas covered: Based on recent evidence, it is clear that AEP cleaves its substrate, such as amyloid precursor protein (APP), tau and SET, and plays a critical role in neuronal cell death in various neurodegenerative diseases and stroke. In this article, the basic biology of AEP, its knockout phenotypes in mouse models, its substrates in neurodegenerative diseases, and its small peptidyl inhibitors and prodrugs are discussed. In addition, we discuss the potential of AEP as a novel therapeutic target for neurodegenerative diseases.
Expert opinion: AEP plays a unique role in numerous biological processes, depending on both pH and context. Most striking is our most recent finding; that AEP is activated in an age-dependent manner and simultaneously cleaves both APP and tau, thereby unifying both major pathological events in AD. Thus, AEP acts as an innovative trigger for neurodegenerative diseases. Inhibition of AEP will provide a disease-modifying treatment for neurodegenerative diseases including AD.
Taylor & Francis Online